Financial Summary (All financials)
| In millions, except per share items | Jan-01-23 | Jan-02-22 | Jan-03-21 | Dec-29-19 |
| Revenues | 545.8 | 430.6 | 204.8 | 349.9 |
| Revenue growth | 26.8% | 110.2% | -41.5% | |
| Cost of goods sold | 482.4 | 373.8 | 253.2 | 71.0 |
| Gross profit | 63.4 | 56.7 | -48.4 | 278.9 |
| Gross margin | 11.6% | 13.2% | -23.6% | 79.7% |
| Sales and marketing | 17.1 | 16.7 | 7.2 | |
| General and administrative | 31.1 | 27.2 | 23.1 | 25.7 |
| EBIT | 63.4 | 56.7 | -36.8 | 34.5 |
| EBIT margin | 11.6% | 13.2% | -18.0% | 9.9% |
| Pre-tax income | 36.0 | 29.4 | -74.7 | 10.3 |
| Income taxes | 0.0 | 0.0 | -17.0 | 1.6 |
| Tax rate | 0.0% | 0.0% | 22.7% | 15.8% |
| Earnings from continuing ops | 31.2 | 23.4 | -57.0 | 9.6 |
| Earnings from discontinued ops | | | -0.1 | |
| Net income | 31.2 | 23.4 | -57.0 | 9.6 |
| Net margin | 5.7% | 5.4% | -27.9% | 2.8% |
| |
| Diluted EPS | $31,217.00 | $23,415.00 | ($56,986.26) | $9,626.00 |
| Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|